Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

REVSØRE SMEDIE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.7% 2.7% 2.7% 2.7% 2.7% 2.7% 2.7% 2.7%   Bankruptcy risk   4.8% 3.4% 2.6% 2.7% 2.6% 3.9% 10.6% 10.3%   Credit score (0-100)   46 55 61 59 61 49 23 24   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   797 980 992 878 880 591 0.0 0.0   EBITDA   275 466 504 385 394 170 0.0 0.0   EBIT   96.3 259 389 312 360 151 0.0 0.0   Pre-tax profit (PTP)   100.3 263.7 382.7 296.5 350.5 149.6 0.0 0.0   Net earnings   63.7 187.9 289.8 233.7 280.0 124.6 0.0 0.0   Pre-tax profit without non-rec. items   100 264 383 296 351 150 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   672 501 386 368 334 314 0.0 0.0   Shareholders equity total   2,774 2,962 1,851 1,785 1,815 1,690 1,190 1,190   Interest-bearing liabilities   0.0 0.0 0.0 242 56.3 129 0.0 0.0   Balance sheet total (assets)   2,974 3,220 2,240 2,256 2,227 2,202 1,190 1,190   Net Debt   -1,875 -2,416 -1,091 -1,466 -1,518 -1,259 -1,190 -1,190     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   797 980 992 878 880 591 0.0 0.0   Gross profit growth   -17.8% 23.0% 1.1% -11.5% 0.2% -32.8% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,974 3,220 2,240 2,256 2,227 2,202 1,190 1,190   Balance sheet change%   0.1% 8.3% -30.4% 0.7% -1.3% -1.1% -46.0% 0.0%   Added value   274.6 465.9 503.8 385.0 433.1 170.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -18 -379 -230 -91 -68 -38 -314 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.1% 26.4% 39.2% 35.6% 41.0% 25.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.4% 8.5% 14.4% 13.9% 16.1% 6.8% 0.0% 0.0%   ROI %   3.7% 9.2% 16.4% 16.1% 18.5% 8.2% 0.0% 0.0%   ROE %   2.3% 6.6% 12.0% 12.9% 15.6% 7.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   93.3% 92.0% 82.7% 79.1% 81.5% 76.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -682.9% -518.7% -216.7% -380.8% -384.9% -738.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 13.6% 3.1% 7.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 13.1% 6.6% 2.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   11.1 10.2 4.6 3.9 4.4 3.6 0.0 0.0   Current Ratio   11.5 10.5 4.8 4.0 4.6 3.7 0.0 0.0   Cash and cash equivalent   1,875.4 2,416.3 1,091.5 1,708.6 1,574.2 1,388.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,101.5 2,460.9 1,465.5 1,417.5 1,481.6 1,375.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   275 466 504 385 433 170 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   275 466 504 385 394 170 0 0   EBIT / employee   96 259 389 312 360 151 0 0   Net earnings / employee   64 188 290 234 280 125 0 0